New BSAVA Formularies covers
BSAVA Unveils 12th Edition Of The Small Animal Formulary
1 week ago 
148 views
The BSAVA has released the 12th edition of the BSAVA Small Animal Formulary Part A: Canine and Feline, and Part B: Exotic Pets.
The cornerstone of the BSAVA Medicines Suite, the Formulary remains one of the Association’s most trusted and widely used clinical resources for veterinary professionals.
Part A: Canine and Feline Formulary
The latest edition of the BSAVA Small Animal Formulary, 12th edition – Part A: Canine and Feline sees Fergus Allerton return as Editor-in-Chief. The drug monographs were thoroughly revised and updated by the Editorial Panel during 2025 to ensure that they provide the most up-to-date information available on the medicines used to treat dogs and cats.
New to the 12th edition:
- New drug monographs have been added, including citalopram, enflicoxib, ilunocitinib and verdinexor
- Drugs that are available as extemporaneous products (also known as ‘veterinary specials’) are denoted as VSP in the formulations section of the monographs
- Information on drugs used for the management of urinary incontinence
- A seizure algorithm, guidance on supplements and nutraceuticals, and expanded information on contrast agents have been added to the Appendix
- There are 7 new client information leaflets that have been added to the existing resource, including bezafibrate, chloramphenicol, clomipramine and memantine
Part B: Exotic Pets Formulary
The BSAVA Small Animal Formulary, 12th edition – Part B: Exotic Pets continues to set the standard for responsible prescribing in the growing and diverse field of exotic animal medicine. The species covered in this edition include mammals, birds, reptiles, amphibians and fish. Under the guidance of Editor-in-Chief, Joanna Hedley, the drug monographs were comprehensively reviewed and updated by the Editorial Panel during 2025.
New to the 12th edition:
- New drug monographs have been added, including afoxolaner, atorvastatin and danofloxacin
- Emergency drug doses for rabbits, rodents, ferrets, birds and reptiles have been added to the inside front cover as a readily accessible reference guide
- Information on barium and iodinated contrast agents for diagnostic imaging has been added to the Appendix. Covering the range of agents available, along with notes on safety and handling, contraindications and complications, this will provide a valuable resource for practitioners
- A suite of routes of administration client information leaflets has been produced covering inhaled medications, injectable medications, oral medications, topical ear medications and topical eye medications
- Additional information on proprietary fish medicines and drug doses for different species of British wildlife, including badgers, deer, foxes and hedgehogs, is available via the BSAVA library
Eligible BSAVA members will receive a printed copy of Part A: Canine and Feline as part of their membership from April 2026 onwards.
All BSAVA members will have access to the online version via the BSAVA library and the BSAVA app from mid-April. Price for a printed copy for BSAVA members is £37.70; Non-members £58.00. For more information and to purchase a copy, visit the BSAVA website: https://bsavaportal.bsava.com/s/store?_gl=1*v2408s*_ga*NTEwNDY3NDk5LjE3NzQ2MTU5MDk.#/store/browse/cat/a0w8d000000Mh3FAAS/tiles.
More from BSAVA
- BSAVA awarded Green Accreditation by Investors in the Environment for sustainability commitment
- The BSAVA welcomes the conclusion of the CMA investigation into the veterinary sector
- BSAVA PetSavers awards funding for master’s degree by research
- BSAVA announce award winners for 2026
- Study highlights high early mortality but potential for treatment to increase short-term survival for Pugs with protein-losing enteropathy
